<DOC>
	<DOCNO>NCT00669357</DOCNO>
	<brief_summary>Abiocor post market approval study Implantable Replacement Heart . This post approval study currently hold .</brief_summary>
	<brief_title>AbioCor Implantable Replacement Heart</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Patients severe biventricular end stage heart disease cardiac transplant candidate adult le 75 year old , require multiple inotropic support , treatable LVAD destination therapy , weanable biventricular support support . Patients irreversible end organ dysfunction would compromise survival , clinical assessment 30 % chance survival beyond 30 day , inadequate psychosocial support , patient fit problem , base preoperative noninvasive anatomical assessment show thoracic volume unable accommodate device .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>End stage heart disease</keyword>
</DOC>